Share on StockTwits

Kindred Healthcare (NYSE:KND) Chairman Edward L. Kuntz unloaded 70,026 shares of the company’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $20.02, for a total transaction of $1,401,920.52. Following the completion of the transaction, the chairman now directly owns 19,337 shares in the company, valued at approximately $387,127. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Kindred Healthcare (NYSE:KND) traded up 3.51% during mid-day trading on Tuesday, hitting $20.95. The stock had a trading volume of 467,249 shares. Kindred Healthcare has a 52-week low of $9.75 and a 52-week high of $21.40. The stock’s 50-day moving average is $19.56 and its 200-day moving average is $16.5. The company’s market cap is $1.135 billion.

Kindred Healthcare (NYSE:KND) last released its earnings data on Thursday, February 20th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.02. Analysts expect that Kindred Healthcare will post $1.13 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Thursday, March 27th. Stockholders of record on Thursday, March 6th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date of this dividend is Tuesday, March 4th.

A number of analysts have recently weighed in on KND shares. Analysts at UBS AG upgraded shares of Kindred Healthcare from an “underperform” rating to a “market perform” rating in a research note on Monday. Separately, analysts at Wells Fargo & Co. upgraded shares of Kindred Healthcare from an “underperform” rating to a “market perform” rating in a research note on Monday. Finally, analysts at Roth Capital initiated coverage on shares of Kindred Healthcare in a research note on Tuesday, February 4th. They set a “buy” rating on the stock. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $19.73.

Kindred Healthcare, Inc is a healthcare services company that through its subsidiaries operates transitional care (NYSE:KND) hospitals, inpatient rehabilitation hospitals (IRFs), nursing and rehabilitation centers, assisted living facilities, a contract rehabilitation services business and a home health and hospice business across the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.